Stockreport

Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema,” “Olema Oncology” or the “Company,” Nasdaq: OLMA), a clinical-stage biopharmaceu [Read more]